Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18908562 | 0.82 | CYP1A2 (0.71) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL30673515 | 0.81 | CYP1A2 (0.67) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL11529594 | 0.80 | HTT (0.61) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL1588109 | 0.79 | ALDH1A1 (0.58) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL10338456 | 0.79 | ALDH1A1 (0.58) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL1587116 | 0.79 | ALDH1A1 (0.58) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL28154948 | 0.79 | CYP1A2 (0.55) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL19872020 | 0.78 | ALDH1A1 (0.56) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL11528671 | 0.77 | TDP1 (0.69) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 | |
| SCHEMBL18532431 | 0.77 | KMT2A (0.58) | KMT2AALDH1A1MAPK1ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210330606-A1 | GLUCOSE CONSUMPTION ACCELERATOR AND GLYCOLYSIS ACCELERATOR | SHINKO SANGYO CO., LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
| WO-2020026471-A1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | 株式会社親広産業 | 2020-02-06 | — | — | WO | disclosed |
| WO-2020026570-A1 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | 株式会社親広産業 | 2020-02-06 | — | — | WO | disclosed |
| EP-1748994-B1 | NITROOXYDERIVATIVES OF ANTIHYPERTENSIVE DRUGS | NICOX SA (FR) | 2009-02-18 | — | — | EP | disclosed |
| US-20070060586-A1 | Nitrooxyderivatives of antihypertensive drugs | NICOX S.A. (FR) | 2007-03-15 | — | — | US | disclosed |
| US-20070060586-A1 | Nitrooxyderivatives of antihypertensive drugs | NICOX S.A. (FR) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060586-A1 | Nitrooxyderivatives of antihypertensive drugs | ADRB2, ADRB1, ADRA2B | KMT2A 3418/4885ALDH1A1 942/4885MAPK1 2054/4885 |
| US-20210330606-A1 | GLUCOSE CONSUMPTION ACCELERATOR AND GLYCOLYSIS ACCELERATOR | SLC2A1, SLC2A2, SLC2A8 | KMT2A 211/4885ALDH1A1 1144/4885MAPK1 259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.